We describe a case of a 79-year-old man with pacemaker who presented to the Emergency Department due to asthenia and acute confusional state. He had a history of atrial fibrillation, anemia and colostomy and he was on treatment with diuretics. The electrocardiogram (ECG) showed pacemaker-induced ventricular activity, QRS complexes excessively wide with sinewave appearance, tall and peaked T waves, without electrically evident atrial activity. Potassium concentration on arterial blood gas analysis was 8.8 mmol/L. ECG abnormalities disappeared after therapy with calcium chloride and spontaneous cardiac activity reappeared.
Introduction
Hyperkalemia, defined as a serum potassium level above 5.5 mEq/L, may affect up to 10% of all hospitalized patients and, in most cases, it is due to medications and renal insufficiency. Hyperkalemia may have dramatic effects on cardiac electrical activity that must be recognized and promptly treated to avoid cardiac arrest. 1 The electrocardiographic changes due to hyperkalemia can be difficult to interpret in patients with pacemaker-dependent cardiac activity.
Case Report
A 79-year-old man presented to the Emergency Room with new onset of pronounced asthenia and acute confusional state. We assigned him a yellow triage-tag and we collected data of his pathological history. He had a pacemaker, a history of atrial fibrillation, anemia and he wore a colostomy bag. He denied allergies. He was on treatment with diuretics, new oral anticoagulant, β-blocker, vitamin supplements and iron. On physical examination he was alert and confused. At admission blood pressure was 90/50 mmHg, heart rate was 85 beats per minute, oxygen saturation was 97% in room air, respiratory rate was 22 breaths per minute and he was afebrile. Chest examination revealed normal vesicular murmur. Cardiovascular examination revealed muffled heart sounds, normal peripheral pulses, no edema. Abdominal examination was normal. Neurologic exam showed confusion and no focal signs. Electrocardiogram (ECG) showed no organized P waves with failure of atrial pacemaker capture, ventricular activity under pacing with extremely large QRS complexes (240 ms) and symmetrically peaked T waves configuring a sine-wave pattern particularly evident in precordial leads ( Figure 1 ). Blood gas analysis showed severe hyperkalemia and metabolic acidosis (Table 1) . Calcium chloride 1 gram was promptly administrated ev over 2 min, followed by 250 mL of 10% dextrose plus insulin 10 units and bicarbonate infusion of 50 mEq. After the first infusion QRS complex promptly narrowed ( Figure 2 ). Laboratory test showed an acute kidney injury and confirmed severe hyperkalemia ( Table 2) . The patient underwent then urgent hemodialysis and he was admitted to sub intensive care unit. 
Discussion
While mild hyperkalemia is usually asymptomatic, high levels of potassium may cause life-threatening cardiac arrhythmias, muscle weakness and paralysis. Symptoms usually develop for values higher than 6.5-7 mEq/L, but the rate of change is more important than the numerical value. 1 Homeostasis of potassium is primary due to kidneys function, with a small contribution of the gastrointestinal tract. Hyperkalemia is most commonly encountered in patients with decreased kidney function. 2 Increases in total body potassium may have dramatic effects on the Electrocardiographic features of hyperkalemia electrocardiogram. The most common changes associated with hyperkalemia are tall, peaked T waves, reduced amplitude and eventually loss of the P waves, PR prolongation, and marked widening of the QRS complexes. Death resulting from hyperkalemia may be due to asystole, ventricular fibrillation, or a wide pulseless idioventricular rhythm. 3 In patients with pacemakers, hyperkalemia can cause three important abnormalities that usually become manifest when the K + level exceeds 7 mEq/L: i) widening of the paced QRS complex from delayed intraventricular conduction velocity; ii) increased atrial and ventricular pacing thresholds, that may cause failure to capture; iii) increased latency manifested by a greater delay of the interval from the pacemaker stimulus to the onset of depolarization. 4 The urgency of early management for hyperkalemia depends on how rapidly the condition develops, the absolute serum potassium level, the degree of symptoms and the cause. Patients with neuromuscular weakness, paralysis or ECG changes and elevated potassium should receive aggressive treatment. Exogenous sources of potassium should be immediately discontinued. Calcium therapy will stabilize the cardiac response to hyperkalemia and should be initiated immediately in the setting of cardiac toxicity. Calcium does not alter the serum concentration of potassium but is the first-line therapy in hyperkalemia related arrhythmias and ECG changes due to its ability to stabilize cardiomyocyte membranes. Insulin and glucose will drive the potassium back into the cells, effectively lowering serum potassium. β-2 adrenergic agents such as albuterol will also shift potassium intracellularly. Sodium bicarbonate infusion may be helpful in patients with metabolic acidosis. Loop or thiazide diuretics may be helpful in enhancing potassium excretion but they may be used in non-oliguric and normally hydrated patients. Gastrointestinal cation exchangers such as patiromer may be helpful. Hemodialysis should be performed when indicated.
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Conclusions
An ECG and a blood gas analysis should be obtained at an early stage in patients with pronounced asthenia. An acute kidney injury should be suspected in case of metabolic acidosis. ECG features of hyperkalemia may be difficult to identify in patients with implantable medical devices. The knowledge of electrocardiographic features of hyperkalemia in a patient with paced cardiac activity is essential to promptly administrate calcium chloride therapy and avoid cardiac arrest.
